Search results for the GEO ID: GSE41386 |
(Click on the check boxes provided under "Select for analysis", to initiate grouping) |
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down) |
|
GSM ID | GPL ID |
Select for analysis |
Title |
Source name |
Description |
Characteristics |
GSM1016021 | GPL570 |
|
Myometrial smooth muscle cell control biological rep1
|
SMCs (passage 3) prepared from normal myometrial tissue samples, treated with scrambled siRNA for 48h
|
tissue: Uterus, normal myometrium
age: Ages 21 - 50
treatment: treated with scrambled siRNA for 48h
|
Gene expression data from control primary myometrial SMCs
|
Sample_geo_accession | GSM1016021
| Sample_status | Public on Oct 06 2012
| Sample_submission_date | Oct 05 2012
| Sample_last_update_date | Oct 06 2012
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Homo sapiens
| Sample_taxid_ch1 | 9606
| Sample_treatment_protocol_ch1 | siRNA (25nM) in Lipofectamine RNAiMAX transfection reagent (Invitrogen/ LifeTechnologies) according to manufacturer's protocol
| Sample_growth_protocol_ch1 | Cells grown in DMEM with FBS (10%) for 24h were treated with scrambled control siRNA or siREST for 48h
| Sample_molecule_ch1 | total RNA
| Sample_extract_protocol_ch1 | RNeasy mini-kit (Qiagen) protocol
| Sample_label_ch1 | biotin
| Sample_label_protocol_ch1 | Biotinylated In-vitro Transcription using the GeneChip 3` IVT Express Kit
| Sample_hyb_protocol | 200ul hybridization solution per GeneChip using GeneChip Hybridization, Wash and Stain Kit.
| Sample_scan_protocol | Single Scan; Affymetrix GeneChip Scanner 3000 7G with Autoloader; Affymetrix GeneChip Command Console (AGCC) ver. 1.1
| Sample_data_processing | The data were analyzed with Partek Genomics Suite version 6.5 (RMA) using RMA default analysis settings: RMA Background Correction; Quantile Normalization; Median Polish probeset summarization.
| Sample_platform_id | GPL570
| Sample_contact_name | Vargheese,M,Chennathukuzhi
| Sample_contact_email | vchennathukuzhi@kumc.edu
| Sample_contact_institute | University of Kansas Medical Center
| Sample_contact_address | 3901 Rainbow Boulevard
| Sample_contact_city | Kansas City
| Sample_contact_state | KS
| Sample_contact_zip/postal_code | 66160
| Sample_contact_country | USA
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1016nnn/GSM1016021/suppl/GSM1016021_A1_051011_HG-U133_Plus_2_.CEL.gz
| Sample_series_id | GSE41386
| Sample_data_row_count | 54675
| |
|
GSM1016022 | GPL570 |
|
Myometrial smooth muscle cell control biological rep2
|
SMCs (passage 3) prepared from normal myometrial tissue samples, treated with scrambled siRNA for 48h
|
tissue: Uterus, normal myometrium
age: Ages 21 - 50
treatment: treated with scrambled siRNA for 48h
|
Gene expression data from control primary myometrial SMCs
|
Sample_geo_accession | GSM1016022
| Sample_status | Public on Oct 06 2012
| Sample_submission_date | Oct 05 2012
| Sample_last_update_date | Oct 06 2012
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Homo sapiens
| Sample_taxid_ch1 | 9606
| Sample_treatment_protocol_ch1 | siRNA (25nM) in Lipofectamine RNAiMAX transfection reagent (Invitrogen/ LifeTechnologies) according to manufacturer's protocol
| Sample_growth_protocol_ch1 | Cells grown in DMEM with FBS (10%) for 24h were treated with scrambled control siRNA or siREST for 48h
| Sample_molecule_ch1 | total RNA
| Sample_extract_protocol_ch1 | RNeasy mini-kit (Qiagen) protocol
| Sample_label_ch1 | biotin
| Sample_label_protocol_ch1 | Biotinylated In-vitro Transcription using the GeneChip 3` IVT Express Kit
| Sample_hyb_protocol | 200ul hybridization solution per GeneChip using GeneChip Hybridization, Wash and Stain Kit.
| Sample_scan_protocol | Single Scan; Affymetrix GeneChip Scanner 3000 7G with Autoloader; Affymetrix GeneChip Command Console (AGCC) ver. 1.1
| Sample_data_processing | The data were analyzed with Partek Genomics Suite version 6.5 (RMA) using RMA default analysis settings: RMA Background Correction; Quantile Normalization; Median Polish probeset summarization.
| Sample_platform_id | GPL570
| Sample_contact_name | Vargheese,M,Chennathukuzhi
| Sample_contact_email | vchennathukuzhi@kumc.edu
| Sample_contact_institute | University of Kansas Medical Center
| Sample_contact_address | 3901 Rainbow Boulevard
| Sample_contact_city | Kansas City
| Sample_contact_state | KS
| Sample_contact_zip/postal_code | 66160
| Sample_contact_country | USA
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1016nnn/GSM1016022/suppl/GSM1016022_A2_051011_HG-U133_Plus_2_.CEL.gz
| Sample_series_id | GSE41386
| Sample_data_row_count | 54675
| |
|
GSM1016023 | GPL570 |
|
Myometrial smooth muscle cell control biological rep3
|
SMCs (passage 3) prepared from normal myometrial tissue samples, treated with scrambled siRNA for 48h
|
tissue: Uterus, normal myometrium
age: Ages 21 - 50
treatment: treated with scrambled siRNA for 48h
|
Gene expression data from control primary myometrial SMCs
|
Sample_geo_accession | GSM1016023
| Sample_status | Public on Oct 06 2012
| Sample_submission_date | Oct 05 2012
| Sample_last_update_date | Oct 06 2012
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Homo sapiens
| Sample_taxid_ch1 | 9606
| Sample_treatment_protocol_ch1 | siRNA (25nM) in Lipofectamine RNAiMAX transfection reagent (Invitrogen/ LifeTechnologies) according to manufacturer's protocol
| Sample_growth_protocol_ch1 | Cells grown in DMEM with FBS (10%) for 24h were treated with scrambled control siRNA or siREST for 48h
| Sample_molecule_ch1 | total RNA
| Sample_extract_protocol_ch1 | RNeasy mini-kit (Qiagen) protocol
| Sample_label_ch1 | biotin
| Sample_label_protocol_ch1 | Biotinylated In-vitro Transcription using the GeneChip 3` IVT Express Kit
| Sample_hyb_protocol | 200ul hybridization solution per GeneChip using GeneChip Hybridization, Wash and Stain Kit.
| Sample_scan_protocol | Single Scan; Affymetrix GeneChip Scanner 3000 7G with Autoloader; Affymetrix GeneChip Command Console (AGCC) ver. 1.1
| Sample_data_processing | The data were analyzed with Partek Genomics Suite version 6.5 (RMA) using RMA default analysis settings: RMA Background Correction; Quantile Normalization; Median Polish probeset summarization.
| Sample_platform_id | GPL570
| Sample_contact_name | Vargheese,M,Chennathukuzhi
| Sample_contact_email | vchennathukuzhi@kumc.edu
| Sample_contact_institute | University of Kansas Medical Center
| Sample_contact_address | 3901 Rainbow Boulevard
| Sample_contact_city | Kansas City
| Sample_contact_state | KS
| Sample_contact_zip/postal_code | 66160
| Sample_contact_country | USA
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1016nnn/GSM1016023/suppl/GSM1016023_A3_051011_HG-U133_Plus_2_.CEL.gz
| Sample_series_id | GSE41386
| Sample_data_row_count | 54675
| |
|
GSM1016024 | GPL570 |
|
Myometrial smooth muscle cell siREST biological rep1
|
SMCs (passage 3) prepared from normal myometrial tissue samples, treated with siREST for 48h
|
tissue: Uterus, normal myometrium
age: Ages 21 - 50
treatment: treated with siREST for 48h
|
Gene expression data from primary myometrial SMCs after REST knockdown
|
Sample_geo_accession | GSM1016024
| Sample_status | Public on Oct 06 2012
| Sample_submission_date | Oct 05 2012
| Sample_last_update_date | Oct 06 2012
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Homo sapiens
| Sample_taxid_ch1 | 9606
| Sample_treatment_protocol_ch1 | siRNA (25nM) in Lipofectamine RNAiMAX transfection reagent (Invitrogen/ LifeTechnologies) according to manufacturer's protocol
| Sample_growth_protocol_ch1 | Cells grown in DMEM with FBS (10%) for 24h were treated with scrambled control siRNA or siREST for 48h
| Sample_molecule_ch1 | total RNA
| Sample_extract_protocol_ch1 | RNeasy mini-kit (Qiagen) protocol
| Sample_label_ch1 | biotin
| Sample_label_protocol_ch1 | Biotinylated In-vitro Transcription using the GeneChip 3` IVT Express Kit
| Sample_hyb_protocol | 200ul hybridization solution per GeneChip using GeneChip Hybridization, Wash and Stain Kit.
| Sample_scan_protocol | Single Scan; Affymetrix GeneChip Scanner 3000 7G with Autoloader; Affymetrix GeneChip Command Console (AGCC) ver. 1.1
| Sample_data_processing | The data were analyzed with Partek Genomics Suite version 6.5 (RMA) using RMA default analysis settings: RMA Background Correction; Quantile Normalization; Median Polish probeset summarization.
| Sample_platform_id | GPL570
| Sample_contact_name | Vargheese,M,Chennathukuzhi
| Sample_contact_email | vchennathukuzhi@kumc.edu
| Sample_contact_institute | University of Kansas Medical Center
| Sample_contact_address | 3901 Rainbow Boulevard
| Sample_contact_city | Kansas City
| Sample_contact_state | KS
| Sample_contact_zip/postal_code | 66160
| Sample_contact_country | USA
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1016nnn/GSM1016024/suppl/GSM1016024_B1_051011_HG-U133_Plus_2_.CEL.gz
| Sample_series_id | GSE41386
| Sample_data_row_count | 54675
| |
|
GSM1016025 | GPL570 |
|
Myometrial smooth muscle cell siREST biological rep2
|
SMCs (passage 3) prepared from normal myometrial tissue samples, treated with siREST for 48h
|
tissue: Uterus, normal myometrium
age: Ages 21 - 50
treatment: treated with siREST for 48h
|
Gene expression data from primary myometrial SMCs after REST knockdown
|
Sample_geo_accession | GSM1016025
| Sample_status | Public on Oct 06 2012
| Sample_submission_date | Oct 05 2012
| Sample_last_update_date | Oct 06 2012
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Homo sapiens
| Sample_taxid_ch1 | 9606
| Sample_treatment_protocol_ch1 | siRNA (25nM) in Lipofectamine RNAiMAX transfection reagent (Invitrogen/ LifeTechnologies) according to manufacturer's protocol
| Sample_growth_protocol_ch1 | Cells grown in DMEM with FBS (10%) for 24h were treated with scrambled control siRNA or siREST for 48h
| Sample_molecule_ch1 | total RNA
| Sample_extract_protocol_ch1 | RNeasy mini-kit (Qiagen) protocol
| Sample_label_ch1 | biotin
| Sample_label_protocol_ch1 | Biotinylated In-vitro Transcription using the GeneChip 3` IVT Express Kit
| Sample_hyb_protocol | 200ul hybridization solution per GeneChip using GeneChip Hybridization, Wash and Stain Kit.
| Sample_scan_protocol | Single Scan; Affymetrix GeneChip Scanner 3000 7G with Autoloader; Affymetrix GeneChip Command Console (AGCC) ver. 1.1
| Sample_data_processing | The data were analyzed with Partek Genomics Suite version 6.5 (RMA) using RMA default analysis settings: RMA Background Correction; Quantile Normalization; Median Polish probeset summarization.
| Sample_platform_id | GPL570
| Sample_contact_name | Vargheese,M,Chennathukuzhi
| Sample_contact_email | vchennathukuzhi@kumc.edu
| Sample_contact_institute | University of Kansas Medical Center
| Sample_contact_address | 3901 Rainbow Boulevard
| Sample_contact_city | Kansas City
| Sample_contact_state | KS
| Sample_contact_zip/postal_code | 66160
| Sample_contact_country | USA
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1016nnn/GSM1016025/suppl/GSM1016025_B2_051011_HG-U133_Plus_2_.CEL.gz
| Sample_series_id | GSE41386
| Sample_data_row_count | 54675
| |
|
GSM1016026 | GPL570 |
|
Myometrial smooth muscle cell siREST biological rep3
|
SMCs (passage 3) prepared from normal myometrial tissue samples, treated with siREST for 48h
|
tissue: Uterus, normal myometrium
age: Ages 21 - 50
treatment: treated with siREST for 48h
|
Gene expression data from primary myometrial SMCs after REST knockdown
|
Sample_geo_accession | GSM1016026
| Sample_status | Public on Oct 06 2012
| Sample_submission_date | Oct 05 2012
| Sample_last_update_date | Oct 06 2012
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Homo sapiens
| Sample_taxid_ch1 | 9606
| Sample_treatment_protocol_ch1 | siRNA (25nM) in Lipofectamine RNAiMAX transfection reagent (Invitrogen/ LifeTechnologies) according to manufacturer's protocol
| Sample_growth_protocol_ch1 | Cells grown in DMEM with FBS (10%) for 24h were treated with scrambled control siRNA or siREST for 48h
| Sample_molecule_ch1 | total RNA
| Sample_extract_protocol_ch1 | RNeasy mini-kit (Qiagen) protocol
| Sample_label_ch1 | biotin
| Sample_label_protocol_ch1 | Biotinylated In-vitro Transcription using the GeneChip 3` IVT Express Kit
| Sample_hyb_protocol | 200ul hybridization solution per GeneChip using GeneChip Hybridization, Wash and Stain Kit.
| Sample_scan_protocol | Single Scan; Affymetrix GeneChip Scanner 3000 7G with Autoloader; Affymetrix GeneChip Command Console (AGCC) ver. 1.1
| Sample_data_processing | The data were analyzed with Partek Genomics Suite version 6.5 (RMA) using RMA default analysis settings: RMA Background Correction; Quantile Normalization; Median Polish probeset summarization.
| Sample_platform_id | GPL570
| Sample_contact_name | Vargheese,M,Chennathukuzhi
| Sample_contact_email | vchennathukuzhi@kumc.edu
| Sample_contact_institute | University of Kansas Medical Center
| Sample_contact_address | 3901 Rainbow Boulevard
| Sample_contact_city | Kansas City
| Sample_contact_state | KS
| Sample_contact_zip/postal_code | 66160
| Sample_contact_country | USA
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1016nnn/GSM1016026/suppl/GSM1016026_B3_051011_HG-U133_Plus_2_.CEL.gz
| Sample_series_id | GSE41386
| Sample_data_row_count | 54675
| |
|
GSM1016027 | GPL570 |
|
Leiomyoma smooth muscle cell control biological rep1
|
SMCs (passage 3) prepared from leiomyoma tissue samples, treated with scrambled siRNA for 48h
|
tissue: Uterus, Leiomyoma
age: Ages 21 - 50
treatment: treated with scrambled siRNA for 48h
|
Gene expression data from control primary leiomyoma (fibroid) SMCs
|
Sample_geo_accession | GSM1016027
| Sample_status | Public on Oct 06 2012
| Sample_submission_date | Oct 05 2012
| Sample_last_update_date | Oct 06 2012
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Homo sapiens
| Sample_taxid_ch1 | 9606
| Sample_treatment_protocol_ch1 | siRNA (25nM) in Lipofectamine RNAiMAX transfection reagent (Invitrogen/ LifeTechnologies) according to manufacturer's protocol
| Sample_growth_protocol_ch1 | Cells grown in DMEM with FBS (10%) for 24h were treated with scrambled control siRNA or siREST for 48h
| Sample_molecule_ch1 | total RNA
| Sample_extract_protocol_ch1 | RNeasy mini-kit (Qiagen) protocol
| Sample_label_ch1 | biotin
| Sample_label_protocol_ch1 | Biotinylated In-vitro Transcription using the GeneChip 3` IVT Express Kit
| Sample_hyb_protocol | 200ul hybridization solution per GeneChip using GeneChip Hybridization, Wash and Stain Kit.
| Sample_scan_protocol | Single Scan; Affymetrix GeneChip Scanner 3000 7G with Autoloader; Affymetrix GeneChip Command Console (AGCC) ver. 1.1
| Sample_data_processing | The data were analyzed with Partek Genomics Suite version 6.5 (RMA) using RMA default analysis settings: RMA Background Correction; Quantile Normalization; Median Polish probeset summarization.
| Sample_platform_id | GPL570
| Sample_contact_name | Vargheese,M,Chennathukuzhi
| Sample_contact_email | vchennathukuzhi@kumc.edu
| Sample_contact_institute | University of Kansas Medical Center
| Sample_contact_address | 3901 Rainbow Boulevard
| Sample_contact_city | Kansas City
| Sample_contact_state | KS
| Sample_contact_zip/postal_code | 66160
| Sample_contact_country | USA
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1016nnn/GSM1016027/suppl/GSM1016027_C1_051011_HG-U133_Plus_2_.CEL.gz
| Sample_series_id | GSE41386
| Sample_data_row_count | 54675
| |
|
GSM1016028 | GPL570 |
|
Leiomyoma smooth muscle cell control biological rep2
|
SMCs (passage 3) prepared from leiomyoma tissue samples, treated with scrambled siRNA for 48h
|
tissue: Uterus, Leiomyoma
age: Ages 21 - 50
treatment: treated with scrambled siRNA for 48h
|
Gene expression data from control primary leiomyoma (fibroid) SMCs
|
Sample_geo_accession | GSM1016028
| Sample_status | Public on Oct 06 2012
| Sample_submission_date | Oct 05 2012
| Sample_last_update_date | Oct 06 2012
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Homo sapiens
| Sample_taxid_ch1 | 9606
| Sample_treatment_protocol_ch1 | siRNA (25nM) in Lipofectamine RNAiMAX transfection reagent (Invitrogen/ LifeTechnologies) according to manufacturer's protocol
| Sample_growth_protocol_ch1 | Cells grown in DMEM with FBS (10%) for 24h were treated with scrambled control siRNA or siREST for 48h
| Sample_molecule_ch1 | total RNA
| Sample_extract_protocol_ch1 | RNeasy mini-kit (Qiagen) protocol
| Sample_label_ch1 | biotin
| Sample_label_protocol_ch1 | Biotinylated In-vitro Transcription using the GeneChip 3` IVT Express Kit
| Sample_hyb_protocol | 200ul hybridization solution per GeneChip using GeneChip Hybridization, Wash and Stain Kit.
| Sample_scan_protocol | Single Scan; Affymetrix GeneChip Scanner 3000 7G with Autoloader; Affymetrix GeneChip Command Console (AGCC) ver. 1.1
| Sample_data_processing | The data were analyzed with Partek Genomics Suite version 6.5 (RMA) using RMA default analysis settings: RMA Background Correction; Quantile Normalization; Median Polish probeset summarization.
| Sample_platform_id | GPL570
| Sample_contact_name | Vargheese,M,Chennathukuzhi
| Sample_contact_email | vchennathukuzhi@kumc.edu
| Sample_contact_institute | University of Kansas Medical Center
| Sample_contact_address | 3901 Rainbow Boulevard
| Sample_contact_city | Kansas City
| Sample_contact_state | KS
| Sample_contact_zip/postal_code | 66160
| Sample_contact_country | USA
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1016nnn/GSM1016028/suppl/GSM1016028_C2_051011_HG-U133_Plus_2_.CEL.gz
| Sample_series_id | GSE41386
| Sample_data_row_count | 54675
| |
|
GSM1016029 | GPL570 |
|
Leiomyoma smooth muscle cell control biological rep3
|
SMCs (passage 3) prepared from leiomyoma tissue samples, treated with scrambled siRNA for 48h
|
tissue: Uterus, Leiomyoma
age: Ages 21 - 50
treatment: treated with scrambled siRNA for 48h
|
Gene expression data from control primary leiomyoma (fibroid) SMCs
|
Sample_geo_accession | GSM1016029
| Sample_status | Public on Oct 06 2012
| Sample_submission_date | Oct 05 2012
| Sample_last_update_date | Oct 06 2012
| Sample_type | RNA
| Sample_channel_count | 1
| Sample_organism_ch1 | Homo sapiens
| Sample_taxid_ch1 | 9606
| Sample_treatment_protocol_ch1 | siRNA (25nM) in Lipofectamine RNAiMAX transfection reagent (Invitrogen/ LifeTechnologies) according to manufacturer's protocol
| Sample_growth_protocol_ch1 | Cells grown in DMEM with FBS (10%) for 24h were treated with scrambled control siRNA or siREST for 48h
| Sample_molecule_ch1 | total RNA
| Sample_extract_protocol_ch1 | RNeasy mini-kit (Qiagen) protocol
| Sample_label_ch1 | biotin
| Sample_label_protocol_ch1 | Biotinylated In-vitro Transcription using the GeneChip 3` IVT Express Kit
| Sample_hyb_protocol | 200ul hybridization solution per GeneChip using GeneChip Hybridization, Wash and Stain Kit.
| Sample_scan_protocol | Single Scan; Affymetrix GeneChip Scanner 3000 7G with Autoloader; Affymetrix GeneChip Command Console (AGCC) ver. 1.1
| Sample_data_processing | The data were analyzed with Partek Genomics Suite version 6.5 (RMA) using RMA default analysis settings: RMA Background Correction; Quantile Normalization; Median Polish probeset summarization.
| Sample_platform_id | GPL570
| Sample_contact_name | Vargheese,M,Chennathukuzhi
| Sample_contact_email | vchennathukuzhi@kumc.edu
| Sample_contact_institute | University of Kansas Medical Center
| Sample_contact_address | 3901 Rainbow Boulevard
| Sample_contact_city | Kansas City
| Sample_contact_state | KS
| Sample_contact_zip/postal_code | 66160
| Sample_contact_country | USA
| Sample_supplementary_file | ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1016nnn/GSM1016029/suppl/GSM1016029_C3_051011_HG-U133_Plus_2_.CEL.gz
| Sample_series_id | GSE41386
| Sample_data_row_count | 54675
| |
|
|
|
Make groups for comparisons |
(2 groups will be compared at a time) |
|
Select GSMs and click on "Add groups" |
Enter the group name here: |
|
|
|